Effect of Shenyan Kangfu Tablets Combined with Piperazine Ferulate Tablets on Microcirculation Disturbance of Patients with Diabetic Nephropathy

ZHU Ji-ying; WANG Ming-xian; QIN Bai-yan; FENG Jia-fu; JIANG Yu

doi:10.13422/j.cnki.syfjx.2014150212

您当前的位置：

首页 >

文章列表页 >

Effect of Shenyan Kangfu Tablets Combined with Piperazine Ferulate Tablets on Microcirculation Disturbance of Patients with Diabetic Nephropathy

更新时间：2024-01-04

- Effect of Shenyan Kangfu Tablets Combined with Piperazine Ferulate Tablets on Microcirculation Disturbance of Patients with Diabetic Nephropathy
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 15, Pages: 212-216(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014150212
  CLC： R692;R587.2
- Published：2014
- 稿件说明：
移动端阅览
ZHU Ji-ying, WANG Ming-xian, QIN Bai-yan, et al. Effect of Shenyan Kangfu Tablets Combined with Piperazine Ferulate Tablets on Microcirculation Disturbance of Patients with Diabetic Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(15): 212-216.
DOI：

ZHU Ji-ying, WANG Ming-xian, QIN Bai-yan, et al. Effect of Shenyan Kangfu Tablets Combined with Piperazine Ferulate Tablets on Microcirculation Disturbance of Patients with Diabetic Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(15): 212-216. DOI： 10.13422/j.cnki.syfjx.2014150212.

摘要

目的：探讨肾炎康复片联合阿魏酸哌嗪片治疗糖尿病肾病的疗效及对微循环障碍的影响。方法：65例患者采用随机按数字法分为观察组和对照组。对照组31例采用常规西医治疗，厄贝沙坦片，150 mg/次，1次/d，口服；观察组34例在对照组治疗的基础上加用肾炎康复片，5片/次，3次/d，口服；阿魏酸哌嗪片，4片/次，3次/d，口服。两组疗程均为12周。检测治疗前后24 h尿微量白蛋白排泄率（UAER）、24 h尿蛋白定量和血清肌酐（Scr）；检测治疗前后血液流变学；检测治疗前后血清一氧化氮（NO）、内皮素1（ET-1）、血栓素（TXB2）、6-酮-前列腺素F_1a）（6-Keto-PGF_1a）、超氧化物歧化酶（SOD）和硫代巴比妥酸比色法检测丙二醛（MDA）水平。结果：观察组疾病疗效总有效率为88.24%，优于对照组的67.74%（P<0.05）；治疗后两组UAER、24 h尿蛋白定量和Scr水平均较治疗前下降（P<0.01），观察组UAER、24 h尿蛋白定量和Scr水平低于对照组（P<0.01）；治疗后观察组全血黏度（低切、高切）、全血还原黏度、血小板聚集指数、血浆黏度和纤维蛋白原的改善优于对照组（P<0.01）；观察组治疗后NO和和6-Keto-PGF_1a水平高于对照组（P<0.01）；治疗后观察组ET-1和TXB2水平低于对照组（P<0.01）；治疗后两组SOD水平升高，观察组SOD水平高于对照组（P<0.01）；两组MDA水平较治疗前下降，观察组MDA水平低于对照组（P<0.01）。结论：在血管紧张素受体拮抗剂（ARB）等药物常规治疗的基础上，肾炎康复片和阿魏酸哌嗪片联合治疗DN能减轻蛋白尿，保护肾功能，其作用机制可能与改善血液流变学、调节血管内皮功能、减轻氧化应激，抑制血小板的黏附聚集，增加肾血流灌注，从而改善肾微循环障碍有关。

Abstract

Objective: To discuss curative efficacy of Shenyan Kangfu tablets combined with piperazine ferulate tablets and influence to microcirculation disturbance in treating diabetic nephropathy(DN). Method: Sixty-five patients were randomly divided into control group (31 cases) and observation group (34 cases) by digital method.Patients in the control group received irbesartan tablets of conventional western medicine treatment with 150 mg/time and 1 time/d.Based on treatment of the control group

patients in the observation group added Shenyan Kangfu tablets with 5 tablets/time and 3 times/d by taken orally

and piperazine ferulate tablets took orally with 4 tablets/time and 3 times/d.Course of treatment in those two groups were both 12 weeks.Before and after treatment

24 hours urinary albumin excretion rate(UAER)

24 hours urine protein quantitation and serum creatinine(Scr) were detected

hemorheology was also detected

levels of serous nitric oxide(NO)

endothelin-1(ET-1)

thromboxane(TXB2)

6-Ketone-prostaglandin F-(la)(6-Keto-PGF-la)and superoxide dismutase(SOD) were detected

level of malondialdehyde(MDA) was measured with thiobarbituric acid chromatometry. Result: Total effective rate of curative efficacy in the observation group was 88.24% superior to 67.74% in the control group(P<0.05).After treatment

compared with time before treatment

levels of UAER

24 hours urine protein quantitatio and Scr in those two groups decreased(P<0.01)

which in the observation group were lower than those in the control group(P<0.01). Amelioration of whole blood viscosity(low shear and high shear)

blood reduced viscosity

platelet aggregation index

plasma viscosity and fibrinogen in the observation group were superior to those in the control group(P<0.01)

levels of NO and 6-Keto-PGF_1a in the observation group were higher than those in the control group(P<0.01)

levels of ET-1 and TXB2 in the observation group were lower than those in the control group(P<0.01)

levels of SOD in those two groups increased and which in the observation group were higher than in the control group(P<0.01)

level of MDA in those two groups decreased and which in the observation group were lower than in the control group(P<0.01). Conclusion: Based on the conventional treatment of angiotensin receptor antagonist(ARB)

Shenyan Kangfu tablets combined with piperazine ferulate tablets could reduce proteinuria and protect renal function for patients of DN

its mechanism may be related to ameliorating hemorheology

regulating vascular endothelial function

reducing oxidative stress

increasing renal perfusion

restraining platelet aggregation and adhesion

so it could ameliorate renal microcirculation disturbance.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of HIF-1α in Diabetic Nephropathy and Improvement Effect of Traditional Chinese Medicine： A Review

Randomized Controlled Study of Baoshen Prescription in Treating Stage Ⅳ Diabetic Nephropathy in Patients with Syndromes of Qi-Yin Deficiency and Kidney Collateral Stasis and Obstruction

Mechanism of Action of Coptidis Rhizoma and Ophiopogonis Radix in Delaying Diabetic Nephropathy Based on EGFR/PI3K/Akt Signaling Pathway

Research Progress on Traditional Chinese Medicine Interventions Targeting NF-κB Signaling Pathway to Improve Diabetic Nephropathy

Mechanism of Dahuang Tangluo Pills in Improving Renal Inflammatory Injury in Diabetic Kidkdey Disease by Regulating AGEs/RAGE/IKK/NF-κB Pathway

Related Author

XIE Jiarun

LIN Haoyu

CHEN Xi

SUN Jia

WANG Ming

QIU Yiting

HONG Shuangshuang

LIU Zhiqiu

Related Institution

School of Traditional Chinese Medicine，Southern Medical University

Zhujiang Hospital of Southern Medical University

Beijing Hospital of Traditional Chinese Medicine（TCM） Affiliated to Capital Medical University

ZHANG Binghou Studio of National Famous TCM Inheritance

Henan Collaborative Innovation Center for Research and Development on the Whole Industry Chain of Yu-Yao，Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰